Skip to main navigation Skip to search Skip to main content

Daniel Raleigh

    1984 …2026

    Research activity per year

    Personal profile

    Biography

    B.A., Chemistry and Mathematics, Humboldt State University, 1981
    Ph.D. Massachusetts Institute of Technology, 1988
    Helen Hay Whitney Fellowship, University of Oxford, 1988-1991
    Postdoctoral Fellow, The DuPont Merck Co., 1991-1993
    Pew Scholar in the Biomedical Sciences 1995-Present

    Research interests

    STRUCTURAL BIOLOGY

    The research in our group is centered upon studies of protein folding, protein structure and the mechanism of amyloid formation. We want to understand how proteins fold to their final three dimensional structure and we want to understand why the folded conformation of proteins is stable. Our work on amyloid formation is directed towards understanding the physical basis for the pathological aggregation of polypeptides in certain diseases. These projects involve a wide range of techniques, including but not limited to: high resolution multidimensional NMR, protein design, stop flow methods, peptide synthesis and protein chemistry.

    PROTEIN FOLDING

    Elucidating how the amino acid sequence determines structure, the protein folding problem, is a central issue in modern structural biology. Our laboratory is currently studying the folding of two proteins, the ribosomal protein L9 and the E3/E1p-binding domain. A second area of interest is the nature of partially folded states of proteins. In recent years it has become clear that many proteins can exist in a partially folded state, known as the molten globule state, which contains a high degree of secondary structure but which lacks fixed tertiary interactions. We are studying the molten globule state formed by a small calcium binding protein, a-lactalbumin. Our studies of natural proteins are complemented by efforts in de novo protein design.

    AMYLOID FORMATION

    In certain diseases normally soluble proteins aggregate to form a dense structure called the amyloid fibril. Amyloid deposits are present in individuals suffering from type-II diabetes, Alzheimer's disease and in patients undergoing kidney dialysis. Little is known about the molecular mechanism of amyloid formation. We are studying amyloid formation by the polypeptides amylin and calcitonin. Amylinis a 37 residue peptide which forms amyloid deposits in type-II diabetes while calcitonin forms amyloid deposits in the thyroid. Our work involves the preparation of the peptides via solid phase peptide synthesis, the characterization of the structure of these molecules and studies of the kinetics of amyloid formation.

    Fingerprint

    Dive into the research topics where Daniel Raleigh is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
    • 1 Similar Profiles

    Collaborations and top research areas from the last five years

    Recent external collaboration on country/territory level. Dive into details by clicking on the dots or